Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ST-02 in Upper Tract Urothelial Carcinoma
NCT06124976Phase 3Recruiting
- Start
- Jun 2024
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ST-02 in upper tract urothelial carcinoma (UTUC). Started Jun 2024; status: recruiting.
02
Drugs
ST-02
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT06124976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06124976.